What is DermResearch?
Founded in 1996 and headquartered in Austin, Texas, DermResearch operates as a premier clinical research site specializing in the evaluation of novel treatments for complex skin conditions such as acne, psoriasis, and eczema. By facilitating a bridge between pharmaceutical sponsors and a diverse participant pool, the company has successfully enrolled over 10,000 individuals in clinical trials. Their business model, which prioritizes accessibility by removing insurance requirements, positions them as a high-volume, reliable partner for Contract Research Organizations (CROs) and global pharmaceutical developers seeking to accelerate drug development timelines through rigorous, data-backed clinical study execution.
How much funding has DermResearch raised?
DermResearch has raised a total of $366K across 2 funding rounds:
Debt
$150K
Debt
$216K
Debt (2020): $150K with participation from PPP
Debt (2021): $216K led by PPP
Key Investors in DermResearch
PPP
Public-Private Partnership
What's next for DermResearch?
With this late-stage capital infusion, DermResearch is well-positioned to scale its clinical trial infrastructure and enhance its technological capabilities for patient recruitment and data management. The strategic allocation of these funds will likely focus on expanding site capacity to accommodate a broader range of therapeutic studies, thereby strengthening the company's competitive moat in the clinical research market. As the demand for specialized dermatological treatments continues to rise, DermResearch is poised to leverage its historical performance and robust participant database to secure further partnerships with major pharmaceutical entities, ensuring long-term growth and sustained leadership in the clinical research landscape.
See full DermResearch company page
